Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis

Objective: The autoimmune disease Multiple Sclerosis (MS) represents a heterogeneous disease pattern with an individual course that may lead to permanent disability. In addition to immuno-modulating therapies patients benefit from symptomatic approaches like intrathecal corticosteroid therapy (ICT),...

Descripción completa

Detalles Bibliográficos
Autores principales: Vohl, Katja, Duscha, Alexander, Gisevius, Barbara, Kaisler, Johannes, Gold, Ralf, Haghikia, Aiden
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395388/
https://www.ncbi.nlm.nih.gov/pubmed/30853935
http://dx.doi.org/10.3389/fneur.2019.00132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395388/
https://www.ncbi.nlm.nih.gov/pubmed/30853935
http://dx.doi.org/10.3389/fneur.2019.00132

Ejemplares similares